Answers are grounded in this paper and cite their sources.
Slides for BOF-2099, Is Quantum Ready for Biology?, a Birds-of-a-Feather session at IEEE Quantum Week 2026 (QCE26), held on 14 September 2026 in Toronto. The session asked what it would take to put a quantum step inside a regulated biopharmaceutical pipeline, organized around three questions: what evidence must accompany a quantum result before a regulated workflow can evaluate it; which biological use cases are credible on noisy intermediate-scale devices, which depend on fault tolerance, and which lack a defensible quantum rationale; and which governance requirements hold in both regimes. This published edition contains the framing (where a regulated pipeline begins, what a computed result must carry before it may influence a regulated decision, and what a quantum device returns), the four seed positions argued in the session, and five segments of supporting material: an error-bounded certificate for reusing cached quantum results; a reproduction of QuASeR's QAOA de novo assembly on PennyLane; a trained variational quantum classifier; a mechanistic fed-batch CHO bioreactor process model under a contract of in-process limits, with a map of where quantum computation has been proposed along an antibody manufacturing process; and the strongest case against the session's own premise. Definitions carry their sources, and the reference lists were checked against primary sources on 13 September 2026. Speaker notes and the slides used to collect input from the room are omitted. Views are the author's own. The artifacts are discussion objects, not AstraZeneca positions, and the four seed positions are arguments assigned for debate. The author's participation in the session is covered by an approved AstraZeneca public release; the other material is independent work in which AstraZeneca has no involvement. BOF-2099 is an accepted session at IEEE Quantum Week 2026; these slides are not an IEEE publication, and IEEE, the IEEE Computer Society and the QCE26 organizing committee neither endorse nor are responsible for their content. Licensed CC BY 4.0, except the portrait photograph of the author.
No takes yet. Share an insight, caveat, or question.
Alexander Chernov (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: